Trial Outcomes & Findings for Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in Croatia (NCT NCT02625844)
NCT ID: NCT02625844
Last Updated: 2016-03-03
Results Overview
Health care personnel time (hours/year) includes preparation, distribution and administration of Erythropoiesis Stimulating Agents (ESAs)
COMPLETED
110 participants
Up to 3 months
2016-03-03
Participant Flow
Patient disposition information was unavailable. Therefore, all participants are represented in one arm.
Participant milestones
| Measure |
Erythropoiesis Stimulating Agents (ESAs)
Healthcare personnel performing anemia care for patients.
|
|---|---|
|
Overall Study
STARTED
|
110
|
|
Overall Study
COMPLETED
|
110
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in Croatia
Baseline characteristics by cohort
| Measure |
Erythropoiesis Stimulating Agents (ESAs)
n=110 Participants
Healthcare personnel performing anemia care for patients.
|
|---|---|
|
Age, Customized
>/= 18 years
|
110 participants
n=99 Participants
|
|
Sex: Female, Male
Female
|
NA Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
NA Participants
n=99 Participants
|
PRIMARY outcome
Timeframe: Up to 3 monthsHealth care personnel time (hours/year) includes preparation, distribution and administration of Erythropoiesis Stimulating Agents (ESAs)
Outcome measures
| Measure |
Erythropoiesis Stimulating Agents (ESAs)
n=110 Participants
Healthcare personnel performing anemia care for patients.
|
|---|---|
|
Average Observed Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents (ESAs)
Other ESAs Site 3
|
48 hours/year
|
|
Average Observed Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents (ESAs)
Other ESAs Site 4
|
22 hours/year
|
|
Average Observed Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents (ESAs)
Monopegylated Site 1
|
38 hours/year
|
|
Average Observed Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents (ESAs)
Monopegylated Site 2
|
15 hours/year
|
|
Average Observed Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents (ESAs)
Monopegylated Site 3
|
17 hours/year
|
|
Average Observed Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents (ESAs)
Monopegylated Site 4
|
5 hours/year
|
|
Average Observed Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents (ESAs)
Other ESAs Site 1
|
143 hours/year
|
|
Average Observed Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents (ESAs)
Other ESAs Site 2
|
39 hours/year
|
Adverse Events
Erythropoiesis Stimulating Agents (ESAs)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
- Publication restrictions are in place
Restriction type: OTHER